Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders Are Bullish About This Utility Stock

AES (NYSE:AES), a global utility that produces electricity from a variety of sources including coal, natural gas, and renewable, had VP of Strategy Gardner Walkup buy 7,500 shares of the company in his IRA earlier this week at an average price of $12.59 (the stock closed today at $12.61). Walkup previously owned about 26,000 shares directly and another 3,000 in his 401(k), so in percentage terms this represents a large increase in his holdings of the stock. Insider purchases by officers are generally a bullish sign for a stock. Since officers already bear a large amount of company risk merely by working for the company, in order for them to buy stock they generally must be confident of its prospects to overpower the reasons for trying to diversify. Walkup’s action also follows a round of direct purchases by a few company insiders in May at prices around $12/share. 

David Shaw

AES is a rarity in the world of utilities- it is a growth company which does not pay a dividend (and year to date the stock has tracked the S&P fairly closely). In the first quarter of 2012 it grew its revenues by 14% and its earnings by 52% over the same period the previous year. Both regulated revenue (which is revenue generated based on rates that are set or managed by a regulator) and non-regulated revenue increased. Alternatively, the company is organized into several divisions which fall into two categories- Generation and Utilities- and both of these categories saw their revenue increase as well. The stock currently trades at a trailing price-to-earnings ratio of 57, but when further growth is projected out the market cap only sits at about 9.5 times forward estimates. The company uses much of its cash generated from operations on capital expenditures, and according to the most recent 10-Q has over 2,200 MW of projects under development in 11 countries.

There is limited hedge fund activity in AES. According to recent 13F filings, the largest hedge fund holder of the stock was D.E. Shaw, which owned 8.1 million shares. The fund has been gradually reducing its holdings as well, having owned 12.1 million shares a year earlier (see more stock picks from D.E. Shaw). Royal Capital, co-managed by Yale Fergang and Robert Medway, held about 3.3 million shares. Royal has been keeping its position constant for some time. Here is a closer look at Royal Capital’s portfolio.

As an electric utility AES has a number of large-cap peers. Among these are Duke Energy (NYSE:DUK) and Edison International (NYSE:EIX). These are more in line with an observer’s expectation of a utility company, paying substantial dividend yields (4.6% and 2.9%, respectively). However, AES has an advantage over them in that both of these companies saw their earnings fall in the last quarter compared to a year ago by 40-50% while AES’s, as stated above, rose by over 50%. Their forward P/E ratios are higher than AES’s as well. One comparable electric utility in the sense of not paying a dividend is Calpine (NYSE:CPN), which is also close to AES in size at an $8.4 billion market cap to AES’s $9.7 billion. Calpine has struggled to be profitable at all, and saw negative revenue growth compared to a year ago and negative profits in Q1. We believe that investors interested in an unconventional utility stock should consider an investment in AES.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!